Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic agent: Antimetabolite

Chemical Name

2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-

Foreign Names

  • Tegafurum (Latin)
  • Tegafur (German)
  • Tégafur (French)
  • Tegafur (Spanish)

Generic Names

  • Tegafur (OS: USAN, DCIT, JAN, BAN)
  • Tégafur (OS: DCF)
  • BRN 0525766 (IS)
  • CCRIS 2762 (IS)
  • EINECS 241-846-2 (IS)
  • FR 1574684 (IS)
  • FT (IS)
  • FT 207 (IS)
  • MJF 12264 (IS)
  • NSC 148958 (IS)
  • WR 220066 (IS)
  • Tegafur (PH: JP XVII)

Brand Names

  • Ai Yi [+ Gimeracil; Oteracil]
    HengRui Medicine, China
  • EES-1 [+ Oteracil, + Gimeracil]
    Elmed Eisai, Japan
  • ESUEEWAN OD T [+ Gimeracil, + Oteracil]
    Sawai Seiyaku, Japan
  • ESUEEWAN T [+ Gimeracil, + Oteracil]
    Sawai Seiyaku, Japan
  • Ftorafur
    Grindeks, Georgia; Grindeks, Lithuania
  • Ftorafur 400 mg
    AS Grindeks, Hungary
  • Ftorafurs
    Grindeks, Latvia
  • Furil [+ Uracil]
    Lotus Pharmaceuticals, Taiwan
  • Futraful
    Otsuka, Indonesia; Taiho, Taiwan; Taiho Yakuhin, Japan
  • Futraful 50%
    Taiho Yakuhin, Japan
  • Icarus
    Koa Isei, Japan
  • NKS-1 OD T [+ Oteracil, + Gimeracil]
    Nippon Kayaku, Japan
  • NKS-1 T [+ Oteracil, + Gimeracil]
    Nippon Kayaku, Japan
  • Qi Xing
    Hua Lu Pharm, China
  • S-1 [+ Gimeracil; Oteracil]
    Taiho, China
  • S-1 NP T [+ Gimeracil, + Oteracil]
    Nipro, Japan
  • S-1KK T [+ Gimeracil, + Oteracil]
    Kobayashi Pharmaceutical, Japan
  • S-1Meiji [+ Gimeracil, + Oteracil]
    Meiji Seika Pharma, Japan
  • S-1TAIHO OD T [+ Gimeracil, + Oteracil]
    Okayama Taiho Yakuhin, Japan
  • Tefudex [+ Uracil]
    Korea United Pharma, Philippines
  • Tegacin
    Patron, Taiwan
  • Tegafur+Uracilo [+ Uracil]
    AC Farma, Peru
  • Tegafur-ShenNong Pharm
    Shennong Pharmaceutical Mechanical, China
  • Tegafur-U-Humanity [+ Uracil]
    BDR Pharmaceuticals, Georgia
  • Tegracil [+ Uracil]
    Shin Poong, South Korea
  • Temeral T [+ Oteracil, + Gimeracil]
    Kyowa Yakuhin, Japan
  • Tenox T [+ Oteracil, + Gimeracil]
    ASKA Seiyaku Asuka, Japan
  • Teroful [+ Uracil]
    Kwang Dong, South Korea
  • Teysuno
    Nordic Group, Cyprus
  • Teysuno [+ Gimeracil, + Oteracil]
    Nordic, Estonia; Nordic, Spain; Nordic Drugs, Denmark; Nordic Drugs, Finland; Nordic Drugs, Norway; Nordic Drugs, Sweden; Nordic Group, Czech Republic; Nordic Group, Lithuania; Nordic Group, Romania; Nordic Group, Slovenia; Nordic Pharma, Belgium; Nordic Pharma, United Kingdom; Nordic Pharma, Netherlands; Nordic Pharma, Slovakia; Stragen Nordic, Greece
  • Teysuno 15mg/4.35mg/11.8mg [+ Gimeracil, + Oteracil]
    Nordic Group, Austria; Nordic Pharma, Germany; Nordic Pharma, Hungary; Nordic Pharma, Luxembourg
  • Teysuno 20mg/5.8mg/15.8mg [+ Gimeracil, + Oteracil]
    Nordic Group, Austria; Nordic Pharma, Germany; Nordic Pharma, Hungary; Nordic Pharma, Luxembourg
  • TS-1 [+ Oteracil, + Gimeracil]
    Taiho Yakuhin, Japan
  • TS-1 OD T [+ Oteracil, + Gimeracil]
    Taiho Yakuhin, Japan
  • TS-ONE [+ Gimeracil, + Oteracil]
    Taiho, Singapore; Taiho, Thailand
  • TS-One [+ Oteracil, + Gimeracil]
    Taiho, Hong Kong
  • UFT [+ Uracil]
    Merck, Egypt; Merck, Lithuania; Merck Serono, Italy; Taiho, Singapore; Taiho, Taiwan; Taiho Yakuhin, Japan
  • Uft [+ Uracil]
    Merck, Mexico
  • UFT E [+ Uracil]
    Taiho Yakuhin, Japan
  • UFT-E [+ Uracil]
    Jeil, South Korea
  • Ufur [+ Uracil]
    American Taiwan Biopharm, Thailand; TTY, Malaysia; TTY Biopharm, Taiwan
  • Utefos
    Mylan, Spain


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.